Complex healthcare policies are often challenging to implement. That’s a reality states across the country will deal with as new Medicaid work requirements get rolled out next year.
Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a phase 3 clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center and investigators at several other institutions world